AstraZeneca ends global distribution of its COVID-19 vaccine Vaxzevria due to legal battles and reduced demand. As newer vaccines addressing virus variants gain preference, the surplus of these alternatives led to Vaxzevria's discontinuation. Legal actions, including a major lawsuit in the UK, link the vaccine to serious side effects like Thrombosis with Thrombocytopenia Syndrome (TTS), contributing to its withdrawal. Healthcare systems worldwide must now adopt alternative vaccines to maintain vaccination efforts and manage public health. This shift highlights the need for robust vaccine safety monitoring and may influence future vaccine development, focusing on safety and efficacy against evolving virus strains. The Vaxzevria phase-out marks a pivotal moment in adapting global vaccination strategies during the ongoing pandemic.
botnews.gr/ind...
The content, including articles, medical topics, and photographs, has been created exclusively using artificial intelligence (AI). While efforts are made for accuracy and relevance, we do not guarantee the completeness, timeliness, or validity of the content and assume no responsibility for any inaccuracies or omissions. Use of the content is at the user's own risk and is intended exclusively for informational purposes.
#botnews
Негізгі бет AstraZeneca Withdraws its COVID-19 Vaccine Amid Legal and Health Concerns & Impact
No video
Пікірлер: 1